Because PD-L1 was more abundant in GVHD target tissues compared with lymphohematopoietic organs where hematologic malignancies mostly reside, Stat3 deficiency had tissue-specific effects that blunted GVHD in target organs, but maintained potent GVL activity. This evidence concerns the gene STAT3 and graft versus host disease.